NO955283D0 - SIN-1A cyklodekstrin-inklusjons-komplekser - Google Patents

SIN-1A cyklodekstrin-inklusjons-komplekser

Info

Publication number
NO955283D0
NO955283D0 NO955283A NO955283A NO955283D0 NO 955283 D0 NO955283 D0 NO 955283D0 NO 955283 A NO955283 A NO 955283A NO 955283 A NO955283 A NO 955283A NO 955283 D0 NO955283 D0 NO 955283D0
Authority
NO
Norway
Prior art keywords
sin
complexes
pct
ions
cyclodextrin
Prior art date
Application number
NO955283A
Other languages
English (en)
Other versions
NO955283L (no
NO311030B1 (no
Inventor
Joseph Geczy
Andrasne Vikom
Jozsef Szejtli
Lajos Szente
Julianna Szeman
Original Assignee
Therabel Research Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therabel Research Sa filed Critical Therabel Research Sa
Publication of NO955283D0 publication Critical patent/NO955283D0/no
Publication of NO955283L publication Critical patent/NO955283L/no
Publication of NO311030B1 publication Critical patent/NO311030B1/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Biophysics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)
  • Detergent Compositions (AREA)
NO19955283A 1994-04-26 1995-12-22 SIN-1A cyklodekstrin-inklusjons-komplekser, fremgangsmate for fremstilling og anvendelse av slike i farmasoytiske blandinger NO311030B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9401183A HU218280B (en) 1994-04-26 1994-04-26 Cyclodextrin inclusion complexes containing sin-1a which are stable intheir solid state, process for their preparation and pharmaceutical compositions containing the comlexes
PCT/HU1995/000011 WO1995029172A1 (en) 1994-04-26 1995-04-25 N-morpholino-n-nitrosaminoacetonitril cyclodextrin inclusion complexes

Publications (3)

Publication Number Publication Date
NO955283D0 true NO955283D0 (no) 1995-12-22
NO955283L NO955283L (no) 1995-12-22
NO311030B1 NO311030B1 (no) 2001-10-01

Family

ID=10985114

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19955283A NO311030B1 (no) 1994-04-26 1995-12-22 SIN-1A cyklodekstrin-inklusjons-komplekser, fremgangsmate for fremstilling og anvendelse av slike i farmasoytiske blandinger

Country Status (32)

Country Link
US (1) US5698535A (no)
EP (1) EP0705255B1 (no)
JP (1) JP3434828B2 (no)
KR (1) KR960703404A (no)
CN (1) CN1060164C (no)
AT (1) ATE197708T1 (no)
AU (1) AU694219B2 (no)
BG (1) BG61974B1 (no)
BR (1) BR9506155A (no)
CA (1) CA2163539C (no)
CZ (1) CZ316395A3 (no)
DE (1) DE69519463T2 (no)
DK (1) DK0705255T3 (no)
ES (1) ES2153897T3 (no)
FI (1) FI956156A (no)
GR (1) GR3035356T3 (no)
HR (1) HRP950249A2 (no)
HU (1) HU218280B (no)
IL (1) IL113491A (no)
LT (1) LT4167B (no)
LV (1) LV11543B (no)
MD (1) MD1419G2 (no)
NO (1) NO311030B1 (no)
NZ (1) NZ285149A (no)
PL (1) PL312183A1 (no)
PT (1) PT705255E (no)
RO (1) RO114449B1 (no)
RU (1) RU2136698C1 (no)
SI (1) SI0705255T1 (no)
SK (1) SK155195A3 (no)
WO (1) WO1995029172A1 (no)
YU (1) YU25995A (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143746A (en) * 1994-01-21 2000-11-07 Icos Corporation Tetracyclic cyclic GMP-specific phosphodiesterase inhibitors, process of preparation and use
WO2001036490A2 (en) * 1999-11-12 2001-05-25 Pitha & Pitha Llc Crystalline mixtures of partial methyl ethers of beta-cyclodextrin and related compounds
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine
TWI321054B (en) 2000-12-19 2010-03-01 California Inst Of Techn Compositions containing inclusion complexes
EP1219306A1 (en) * 2000-12-29 2002-07-03 Nicox S.A. Compositions comprising cyclodextrins and NO- releasing drugs
PT2277551E (pt) 2002-09-06 2013-08-22 Cerulean Pharma Inc Polímeros à base de ciclodextrina para a administração de medicamentos ligados por ligação covalente
AU2003295344B2 (en) * 2002-10-09 2008-01-31 Insert Therapeutics, Inc. Cyclodextrin-based materials, compositions and uses related thereto
JP2010516625A (ja) 2007-01-24 2010-05-20 インサート セラピューティクス， インコーポレイテッド 制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート
AU2010321533A1 (en) * 2009-11-23 2012-05-31 Cerulean Pharma Inc. Cyclodextrin-based polymers for therapeutic delivery
WO2014055493A1 (en) 2012-10-02 2014-04-10 Cerulean Pharma Inc. Methods and systems for polymer precipitation and generation of particles
WO2019074886A1 (en) 2017-10-09 2019-04-18 Terumo Bct Biotechnologies, Llc LYOPHILIZATION CONTAINER AND METHOD OF USE
EP3937878A2 (en) 2019-03-14 2022-01-19 Terumo BCT Biotechnologies, LLC Lyophilization loading tray assembly and system
CN116249522A (zh) * 2020-07-20 2023-06-09 深圳迈瑞生物医疗电子股份有限公司 一种组合物的血小板解聚用途、解聚试剂及解聚方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208233A (en) * 1989-09-15 1993-05-04 The United States Of America As Represented By The Department Of Health And Human Services Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
US5039705A (en) * 1989-09-15 1991-08-13 The United States Of America As Represented By The Department Of Health And Human Services Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
US5212204A (en) * 1989-10-18 1993-05-18 The United States Of America As Represented By The Department Of Health And Human Services Antihypertensive compositions and use thereof
HU212730B (en) * 1990-03-28 1996-10-28 Chinoin Gyogyszer Es Vegyeszet Process for producing inclusion complexes of cyclodextrine or its derivative and 3-morpholino-sydnonimine or its salt or its tautomer and pharmaceutical compositions containing them
ES2112332T3 (es) * 1991-09-24 1998-04-01 Us Health Derivados de substitucion de oxigeno de productos de adicion de nucleofilo-oxido nitrico utilizados como promedicamentos donadores de oxido nitrico.
US5389675A (en) * 1992-03-27 1995-02-14 The United States Of America As Represented By The Department Of Health And Human Services Mixed ligand metal complexes of nitric oxide-nucleophile adducts useful as cardiovascular agents

Also Published As

Publication number Publication date
WO1995029172A1 (en) 1995-11-02
NZ285149A (en) 1998-06-26
DE69519463T2 (de) 2001-06-28
PT705255E (pt) 2001-05-31
LV11543A (lv) 1996-10-20
CA2163539A1 (en) 1995-11-02
MD950440A (en) 1997-10-31
LV11543B (en) 1996-12-20
IL113491A (en) 2002-03-10
CN1060164C (zh) 2001-01-03
HU218280B (en) 2000-07-28
AU2415995A (en) 1995-11-16
FI956156A0 (fi) 1995-12-20
RU2136698C1 (ru) 1999-09-10
BG100313A (bg) 1996-07-31
LT95133A (en) 1996-10-25
EP0705255A1 (en) 1996-04-10
AU694219B2 (en) 1998-07-16
CN1128028A (zh) 1996-07-31
FI956156A (fi) 1995-12-20
LT4167B (en) 1997-06-25
SK155195A3 (en) 1997-05-07
US5698535A (en) 1997-12-16
YU25995A (sh) 1998-08-14
DE69519463D1 (de) 2000-12-28
DK0705255T3 (da) 2000-12-11
RO114449B1 (ro) 1999-04-30
HUT70750A (en) 1995-10-30
NO955283L (no) 1995-12-22
ES2153897T3 (es) 2001-03-16
KR960703404A (ko) 1996-08-17
JPH09503546A (ja) 1997-04-08
CZ316395A3 (en) 1996-05-15
BG61974B1 (bg) 1998-11-30
NO311030B1 (no) 2001-10-01
SI0705255T1 (en) 2001-04-30
HU9401183D0 (en) 1994-07-28
CA2163539C (en) 2003-04-01
ATE197708T1 (de) 2000-12-15
HRP950249A2 (en) 1997-10-31
GR3035356T3 (en) 2001-05-31
MD1419G2 (ro) 2000-11-30
BR9506155A (pt) 1996-04-16
MD1419F2 (en) 2000-02-29
EP0705255B1 (en) 2000-11-22
PL312183A1 (en) 1996-04-01
JP3434828B2 (ja) 2003-08-11
IL113491A0 (en) 1995-07-31

Similar Documents

Publication Publication Date Title
DK0705255T3 (da) N-morpholino-N-nitrosaminoacetonitril-cyclodextrin-inklusionskomplekser
RU95120098A (ru) Фосфонометилированные хитозаны
Weil‐Malherbe Activators and inhibitors of brain glutaminase
PT84491B (pt) Processo de preparacao de sulfato de dermatano de alta pureza, e de composicoes farmaceuticas que o contem
US5466846A (en) Process for preparation of stable aqueous solutions of zirconium chelates
RU96100760A (ru) Новые комплексы включения sin-1a и циклодекстрина
KR910011645A (ko) 수성 베타 수산화 코발트(ii) 및 그의 제조방법
JPS5935B2 (ja) ウロキナ−ゼの精製法
AU1131288A (en) A method for making and a slow release composition for abating acid water formation
GB1270448A (en) Heavy metal complexes of cephalosporin c and process for the isolation of cephalosporin c in the form of such complexes
SU1353727A1 (ru) Способ получени кристаллического двойного фосфата титана и магни общей формулы @ -TI MG(РО @ ) @ 3Н @ О
GB1317159A (en) Manufacture of cephalosporin compounds
KR950003168A (ko) 산화제이철의 제조방법
KR970073342A (ko) 은(Ag) 함유 무기 항균제의 제조방법
JPH0655853B2 (ja) 可溶性テルル組成物
JPH0959165A (ja) 安定化ポリヨウ化物製剤の製造法
TH10349EX (th) กรรมวิธีสำหรับเตรียมผลิตภัณฑ์ออกซิไดส์ เซลลูโลส ที่ทำให้เป็นกลางและวิธีการใช้
JPH0280311A (ja) 水酸アパタイトの湿式合成法
JPH0653753B2 (ja) ヘキソースリン酸金属塩及びその製造法
JPS63229057A (ja) 安定な第一鉄化合物水溶液
KR940008679A (ko) 수용성 비스무스 화합물의 제조방법

Legal Events

Date Code Title Description
MK1K Patent expired